Clariane Future Growth

Future criteria checks 3/6

Clariane is forecast to grow earnings and revenue by 112% and 4.9% per annum respectively. EPS is expected to grow by 132.8% per annum. Return on equity is forecast to be 3% in 3 years.

Key information

112.0%

Earnings growth rate

132.8%

EPS growth rate

Healthcare earnings growth19.9%
Revenue growth rate4.9%
Future return on equity3.0%
Analyst coverage

Low

Last updated29 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:KRNM.F - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,8321616279154
12/31/20255,531945438324
12/31/20245,254-464957543
6/30/20245,170-129570934N/A
3/31/20245,083-111445869N/A
12/31/20234,996-92320804N/A
9/30/20234,865-32244799N/A
6/30/20234,73528168794N/A
3/31/20234,58732204828N/A
12/31/20224,43836239862N/A
6/30/20224,28885348900N/A
3/31/20224,21292330870N/A
12/31/20214,137100311840N/A
9/30/20214,04776279818N/A
6/30/20213,94160243785N/A
3/31/20213,85750259790N/A
12/31/20203,77339275795N/A
9/30/20203,72857310765N/A
6/30/20203,68374346734N/A
3/31/20203,64894393750N/A
12/31/20193,613115439766N/A
9/30/20193,542117352687N/A
6/30/20193,471119264607N/A
3/31/20193,404121188492N/A
12/31/20183,336123113377N/A
9/30/20183,280152139371N/A
6/30/20183,224180165364N/A
3/31/20183,177172N/A375N/A
12/31/20173,131163N/A385N/A
9/30/20173,091150N/A353N/A
6/30/20173,052137N/A320N/A
3/31/20173,017134N/A314N/A
12/31/20162,981131N/A307N/A
9/30/20162,88087N/A296N/A
6/30/20162,77942N/A284N/A
3/31/20162,67650N/A264N/A
12/31/20152,57359N/A245N/A
9/30/20152,55377N/A271N/A
6/30/20152,53395N/A297N/A
3/31/20152,37878N/A272N/A
12/31/20142,22261N/A247N/A
9/30/20141,93844N/A186N/A
6/30/20141,65427N/A126N/A
3/31/20141,50528N/A122N/A
12/31/20131,35629N/A119N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KRNM.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: KRNM.F is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: KRNM.F is expected to become profitable in the next 3 years.

Revenue vs Market: KRNM.F's revenue (4.9% per year) is forecast to grow slower than the US market (8.8% per year).

High Growth Revenue: KRNM.F's revenue (4.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: KRNM.F's Return on Equity is forecast to be low in 3 years time (3%).


Discover growth companies